Form 8-K - Current report:
SEC Accession No. 0001193125-26-059349
Filing Date
2026-02-19
Accepted
2026-02-19 16:06:08
Documents
10
Period of Report
2026-02-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K kpti-20260218.htm   iXBRL 8-K 75716
  Complete submission text file 0001193125-26-059349.txt   189452

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kpti-20260218.xsd EX-101.SCH 30858
12 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20260218_htm.xml XML 4700
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 26654359
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)